• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一位 28 岁男性,弥漫性双侧肺结节。

A 28-Year-Old Man With Diffuse Bilateral Pulmonary Nodules.

机构信息

Department of Medicine, Division of Pulmonary and Critical Care Medicine, Albany Medical Center, Albany, NY.

Department of Pediatrics, Division of Pediatric Critical Care, Albany Medical Center, Albany, NY.

出版信息

Chest. 2022 Jul;162(1):e9-e13. doi: 10.1016/j.chest.2022.02.022.

DOI:10.1016/j.chest.2022.02.022
PMID:35809963
Abstract

A 28-year-old man with a history of congenital HIV sought treatment at the ED with a chief symptom of generalized malaise and confusion of 3 days' duration. He had mild dyspnea, but no respiratory distress, and he reported no fever, chest pain, or headache. We were unable to obtain past medical, family, or social history because of encephalopathy and we had no available contact person. Review of the patient's medical record revealed he made an initial clinic visit to the Department of Pediatric Infectious Disease 5 years previously. At the time of that visit, CD4 count was 250 cells/mm and no known complications of HIV were documented. He was prescribed Stribild (elvitegravir-cobicistat-emtricitabine-tenofovir disoproxil fumarate) and darunavir; however, pharmacy records revealed he did not fill the prescriptions. He underwent no further clinic follow-up examinations. He grew up in California and moved to upstate New York 5 years previously.

摘要

一位 28 岁的男子,自幼感染 HIV,因全身不适和意识混乱 3 天到急诊就诊。他有轻度呼吸困难,但无呼吸窘迫,无发热、胸痛或头痛。由于患者有脑病,我们无法获得既往病史、家族史或社会史,也没有可联系的人员。查看患者的病历,发现他 5 年前曾首次到儿科传染病科就诊。当时 CD4 计数为 250 个细胞/毫米,无 HIV 并发症的记录。他当时被开了 Stribild(艾维雷韦/考比司他/恩曲他滨/替诺福韦艾拉酚胺富马酸盐)和达芦那韦,但药房记录显示他没有拿药。此后他没有再进行门诊随访检查。他在加利福尼亚长大,5 年前搬到了纽约州北部。

相似文献

1
A 28-Year-Old Man With Diffuse Bilateral Pulmonary Nodules.一位 28 岁男性,弥漫性双侧肺结节。
Chest. 2022 Jul;162(1):e9-e13. doi: 10.1016/j.chest.2022.02.022.
2
Patient-Reported Symptoms Over 48 Weeks in a Randomized, Open-Label, Phase IIIb Non-Inferiority Trial of Adults with HIV Switching to Co-Formulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir DF versus Continuation of Non-Nucleoside Reverse Transcriptase Inhibitor with Emtricitabine and Tenofovir DF.在一项针对转换为复方依非韦伦、考比司他、恩曲他滨和替诺福韦酯的成人与继续使用含恩曲他滨和替诺福韦酯的非核苷类逆转录酶抑制剂的随机、开放标签、IIIb期非劣效性试验中,患者报告的48周症状。
Patient. 2015 Aug;8(4):359-71. doi: 10.1007/s40271-015-0129-9.
3
A Review of the Efficacy and Safety of Genvoya® (Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide) in the Management of HIV-1 Infection.捷扶康(艾维雷韦、考比司他、恩曲他滨和替诺福韦艾拉酚胺)用于治疗HIV-1感染的疗效和安全性综述
J Pharm Pract. 2018 Apr;31(2):216-221. doi: 10.1177/0897190017710519. Epub 2017 May 30.
4
Safety, efficacy, and pharmacokinetics of a single-tablet regimen containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in treatment-naive, HIV-infected adolescents: a single-arm, open-label trial.在初治的 HIV 感染青少年中,含有艾维雷韦、考比司他、恩曲他滨和替诺福韦艾拉酚胺的单片复方制剂的安全性、疗效和药代动力学:一项单臂、开放标签试验。
Lancet HIV. 2016 Dec;3(12):e561-e568. doi: 10.1016/S2352-3018(16)30121-7. Epub 2016 Oct 17.
5
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection.埃替拉韦/考比司他/恩曲他滨/替诺福韦酯治疗初发或近期HIV感染的疗效。
J Antimicrob Chemother. 2017 Feb;72(2):632-633. doi: 10.1093/jac/dkw439. Epub 2016 Oct 17.
6
Brief Report: A Randomized, Double-Blind Comparison of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate, Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine for Initial HIV-1 Treatment: Week 96 Results.简要报告:替诺福韦艾拉酚胺与富马酸替诺福韦二吡呋酯随机双盲比较,二者均与埃替格韦、考比司他和恩曲他滨联合用于初治HIV-1感染:第96周结果
J Acquir Immune Defic Syndr. 2016 May 1;72(1):58-64. doi: 10.1097/QAI.0000000000000940.
7
Tenofovir alafenamide, emtricitabine, elvitegravir, and cobicistat combination therapy for the treatment of HIV.替诺福韦艾拉酚胺、恩曲他滨、埃替格韦和考比司他联合疗法治疗HIV。
Expert Rev Anti Infect Ther. 2017 Mar;15(3):195-209. doi: 10.1080/14787210.2017.1286736. Epub 2017 Feb 8.
8
Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide for the treatment of HIV in adults.艾维雷韦、考比司他、恩曲他滨和替诺福韦艾拉酚胺用于治疗成人HIV感染。
Expert Opin Pharmacother. 2016;17(3):409-19. doi: 10.1517/14656566.2016.1129401.
9
Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV-infected patients in clinical practice: results from a multicentre, observational study.在临床实践中,转换使用多替拉韦加拉米夫定/恩曲他滨/富马酸替诺福韦二吡呋酯(TDF)或艾维雷韦/考比司他/恩曲他滨/TDF 治疗病毒学抑制的 HIV 感染患者的疗效和安全性:一项多中心、观察性研究的结果。
HIV Med. 2019 Feb;20(2):164-168. doi: 10.1111/hiv.12688. Epub 2018 Nov 20.
10
Stribild® (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate): a new paradigm for HIV-1 treatment.绥美凯(埃替拉韦/考比司他/恩曲他滨/替诺福韦酯富马酸盐):一种HIV-1治疗的新范例。
AIDS Rev. 2014 Jan-Mar;16(1):35-42.